Zhang Kaizhi, Xiang Shanshan, Zhou Jiangyuan, Qiu Tong, Lan Yuru, Ji Yi
Division of Oncology, Department of Pediatric Surgery, West China Hospital of Sichuan University, No. 37 Guo Xue Alley, Chengdu, 610041, China.
Orphanet J Rare Dis. 2025 Jul 7;20(1):345. doi: 10.1186/s13023-025-03899-7.
PHACE syndrome rarely occurs in patients with infantile hemangioma (IH) but is common in patients with segmental IH involving the head and face. PHACE syndrome involves at least one system abnormality, including arterial abnormalities, structural brain abnormalities, cardiovascular abnormalities, eye abnormalities, and ventral or midline abnormalities. The pathogenesis of PHACE syndrome remains unclear, and it affects various systems in diverse ways. Oral propranolol has good effects on patients with PHACE syndrome. However, there are great challenges in the management of patients with PHACE syndrome in the later stage, including headaches, stroke, neurodevelopment impairment, psychosocial impacts, and poor quality of life. Therefore, this review summarizes the epidemiology, risk factors, pathogenesis, clinical manifestations, diagnosis, treatment, and complications of PHACE syndrome. The latest research on and therapeutic prospects for PHACE syndrome are also discussed.
PHACE综合征很少发生于婴儿血管瘤(IH)患者,但在累及头面部的节段性IH患者中很常见。PHACE综合征涉及至少一种系统异常,包括动脉异常、脑结构异常、心血管异常、眼部异常以及腹部或中线异常。PHACE综合征的发病机制尚不清楚,且以多种方式影响不同系统。口服普萘洛尔对PHACE综合征患者有良好疗效。然而,PHACE综合征患者后期的管理存在巨大挑战,包括头痛、中风、神经发育损害、社会心理影响以及生活质量差。因此,本综述总结了PHACE综合征的流行病学、危险因素、发病机制、临床表现、诊断、治疗及并发症。还讨论了PHACE综合征的最新研究及治疗前景。